IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,529,155 | +29.6% | 336,078 | +100.6% | 0.00% | +100.0% |
Q2 2023 | $1,179,594 | +65.5% | 167,556 | +43.6% | 0.00% | 0.0% |
Q1 2023 | $712,768 | -2.7% | 116,656 | +1.7% | 0.00% | 0.0% |
Q4 2022 | $732,652 | -47.9% | 114,656 | -22.3% | 0.00% | -50.0% |
Q3 2022 | $1,406,000 | -5.8% | 147,556 | +9.1% | 0.00% | 0.0% |
Q2 2022 | $1,493,000 | -44.3% | 135,256 | -16.0% | 0.00% | 0.0% |
Q1 2022 | $2,680,000 | +1.2% | 160,968 | +16.0% | 0.00% | 0.0% |
Q4 2021 | $2,648,000 | -18.3% | 138,724 | +5.5% | 0.00% | -33.3% |
Q3 2021 | $3,241,000 | +10.7% | 131,444 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,927,000 | -41.9% | 131,444 | -17.5% | 0.00% | -50.0% |
Q1 2021 | $5,042,000 | -44.6% | 159,264 | -18.8% | 0.01% | -45.5% |
Q4 2020 | $9,101,000 | +60.4% | 196,142 | +13.8% | 0.01% | +37.5% |
Q3 2020 | $5,673,000 | +19.9% | 172,315 | 0.0% | 0.01% | +14.3% |
Q2 2020 | $4,730,000 | +0.8% | 172,315 | +9.9% | 0.01% | -12.5% |
Q1 2020 | $4,694,000 | +1.2% | 156,808 | -6.4% | 0.01% | +14.3% |
Q4 2019 | $4,639,000 | +48.4% | 167,608 | -2.4% | 0.01% | +40.0% |
Q3 2019 | $3,127,000 | -22.8% | 171,808 | +3.9% | 0.01% | -16.7% |
Q2 2019 | $4,053,000 | +289.3% | 165,308 | +51.0% | 0.01% | +200.0% |
Q1 2019 | $1,041,000 | +6.9% | 109,508 | -0.5% | 0.00% | 0.0% |
Q4 2018 | $974,000 | -15.5% | 110,008 | +7.4% | 0.00% | 0.0% |
Q3 2018 | $1,152,000 | -8.9% | 102,400 | +3.6% | 0.00% | 0.0% |
Q2 2018 | $1,265,000 | -2.0% | 98,800 | +29.3% | 0.00% | 0.0% |
Q1 2018 | $1,291,000 | – | 76,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |